Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Adjuvanted Hepatitis B Vaccine Formulations in Healthy Adults
NCT00697970Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 1993
- Primary completion
- Apr 1995
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Nov 1993; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697970.